Drug regulation & therapeutic efficacy.
作者信息
Ritter J M
出版信息
Br J Clin Pharmacol. 2008 Jun;65(6):801-2. doi: 10.1111/j.1365-2125.2008.03208.x.
Abstract
摘要
相似文献
1
Drug regulation & therapeutic efficacy.药物监管与治疗效果。
Br J Clin Pharmacol. 2008 Jun;65(6):801-2. doi: 10.1111/j.1365-2125.2008.03208.x.
2
[Basic principles of clinical evaluation of medications].
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2005 Apr;48(4):395-6. doi: 10.1007/s00103-005-1051-4.
3
[The safety and registration of pharmaceuticals from the point of view of the medical practitioner].从执业医师角度看药品的安全性与注册
Radiologe. 2002 Dec;42(12):1016-24; quiz 1024-5. doi: 10.1007/s00117-002-0847-6.
4
Inquiry says that "UK drugs policy is failing".调查称“英国毒品政策正在失灵”。
Lancet. 2019 Nov 2;394(10209):1605. doi: 10.1016/S0140-6736(19)32673-X.
5
An Open Letter to Health Canada.致加拿大卫生部的一封公开信。
J Cutan Med Surg. 2017 May/Jun;21(3):195-196. doi: 10.1177/1203475417704642.
6
European Medicines Agency assesses safety reporting at Roche.欧洲药品管理局评估罗氏公司的安全报告。
Lancet Oncol. 2012 Aug;13(8):e331. doi: 10.1016/s1470-2045(12)70297-8.
7
Law, medicines and the doctor: a critical look at drug regulation.法律、药品与医生：对药品监管的批判性审视。
Curr Med Res Opin. 1973;1(10):612-28. doi: 10.1185/03007997309111730.
8
Regulatory advice on evaluation of the proarrhythmic potential of drugs.关于药物致心律失常潜力评估的监管建议。
J Electrocardiol. 2004;37 Suppl:40-1. doi: 10.1016/j.jelectrocard.2004.08.007.
9
Health (drugs and poisons) regulation 1996. The implications for nurses.1996年《健康（药物与毒物）条例》。对护士的影响。
Qld Nurse. 1997 Jan-Feb;16(1):24-5.
10
Counterfeit drugs pose growing health threat.假药对健康构成的威胁日益严重。
Am J Health Syst Pharm. 2010 Nov 15;67(22):1896, 1898. doi: 10.2146/news100076.
引用本文的文献
1
Hippocratic oath and conversion of ethico-regulatory aspects onto doctors as a physician, private individual and a clinical investigator.希波克拉底誓言以及将伦理监管方面转化应用于作为医生、个体和临床研究者的医生身上。
J Midlife Health. 2013 Oct;4(4):203-9. doi: 10.4103/0976-7800.122232.
本文引用的文献
1
Brain histamine H1 receptor occupancy of orally administered antihistamines, bepotastine and diphenhydramine, measured by PET with 11C-doxepin.通过使用11C-多塞平的正电子发射断层扫描（PET）测量口服抗组胺药贝波司汀和苯海拉明后大脑组胺H1受体占有率。
Br J Clin Pharmacol. 2008 Jun;65(6):811-21. doi: 10.1111/j.1365-2125.2008.03143.x. Epub 2008 Apr 11.
2
Systemic and bronchodilator effects of inhaled rac-formoterol in subjects with chronic obstructive pulmonary disease: a dose-response study.吸入消旋福莫特罗对慢性阻塞性肺疾病患者的全身及支气管扩张作用：一项剂量反应研究。
Br J Clin Pharmacol. 2008 Jun;65(6):841-7. doi: 10.1111/j.1365-2125.2007.03081.x. Epub 2008 Apr 3.
3
Thrombolysis or nothing for acute myocardial infarction? It's all the same!急性心肌梗死是选择溶栓治疗还是放弃治疗？其实都一样！
Br J Clin Pharmacol. 2008 Jun;65(6):955-8. doi: 10.1111/j.1365-2125.2008.03125.x. Epub 2008 Apr 1.
4
Clinically informative measures of the effect of drugs or other interventions.药物或其他干预措施效果的临床信息性测量指标。
Br J Clin Pharmacol. 2008 Jun;65(6):935-41. doi: 10.1111/j.1365-2125.2008.03146.x. Epub 2008 Mar 13.
5
Minimising harm: human variation and adverse drug reactions (ADRs).减少伤害：人类差异与药物不良反应（ADR）
Br J Clin Pharmacol. 2008 Apr;65(4):451-2. doi: 10.1111/j.1365-2125.2008.03170.x.
6
Venetian treacle and the foundation of medicines regulation.威尼斯糖蜜与药品监管的基础
Br J Clin Pharmacol. 2004 Sep;58(3):317-25. doi: 10.1111/j.1365-2125.2004.02147.x.
7
Meta-analysis of 2-treatment clinical trials including both continuous and dichotomous results.对包含连续和二分结果的双治疗临床试验进行的荟萃分析。
Med Decis Making. 2004 May-Jun;24(3):299-312. doi: 10.1177/0272989X04265437.
8
Confidence intervals for the number needed to treat.治疗所需人数的置信区间。
BMJ. 1998 Nov 7;317(7168):1309-12. doi: 10.1136/bmj.317.7168.1309.
Zotero 插件